SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (491)2/1/1998 5:39:00 PM
From: BigKNY3  Respond to of 9523
 
An analysts' meeting on Monsanto this Wednesday could have an effect on PFE.

Dow Jones is reporting that Searle may announce a marketing partner for its Cox2 antiarthric next Wednesday. "Analysts have named PFE and LLY as possible candidates for the agreement."

Gruntal: "Certainly, someone of PFE's caliber would allay people's concerns (about MRK's Cox-II agent)...Searle is going to need a partner and PFE is the best that there is, other than MRK."

BigKNY3